Accelleron is accelerating sustainability in the marine and energy industries as a global technology leader in turbocharging, fuel injection, and digital solutions for heavy-duty applications. Building on a heritage of over 100 years as a trusted
About Us Rothschild & Co is a leading global financial services group with seven generations of family control and a history of over 200 years at the centre of the worlds financial markets. Our expertise, intellectual
Responsibilities: Manage and lead GRC Teams Develop and implement the GRC strategy and framework. Oversees information security risk assessments and identify potential threats and vulnerabilities. Covers GRC in scope of IT, OT, and Product Security in collaboration with
Responsibilities: Manage and lead GRC Teams Develop and implement the GRC strategy and framework. Oversees information security risk assessments and identify potential threats and vulnerabilities. Covers GRC in scope of IT, OT, and Product Security in collaboration with
As a member of the Compliance team, you will play a key role in delivering the Compliance mandate to Zurich’s Group Functions, with a particular focus on Dealing in Securities well as Anti-Trust and Fair Competition. In
MISSION The Chief Information Security Officer (CISO) will establish, lead, and continuously enhance the Group’s information security strategy. Based in Geneva, the CISO will be responsible for protecting digital assets, ensuring compliance with international regulations, and fostering a
Are you a customer-obsessed Solution Architect with a passion for helping customers achieve their full potential? Do you have a background in Migrating and Modernization on-premise workloads to a cloud hyperscaler, do you also have commercial
The opportunity : Financial Crime Operations Specialist Being part of HSBC in Switzerland, you’ll help evolve and grow our business. The Financial Crime Operations Specialist supports the review and systematic investigation of Anti-Money Laundering (AML) alerts
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON)
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON)
Are you ready to operate at the core of a leading Investment Solution franchise? We are looking for an experienced Exotic Derivatives Trader to join our Zurich-based team, within a market-leading team. This role combines trading
Line of ServiceAssurance Industry/SectorNot Applicable SpecialismAssurance Management LevelSenior Associate Job Description & SummaryAt PwC, our people in audit and assurance focus on providing independent and objective assessments of financial statements, internal controls, and other assurable information
At Julius Baer, we celebrate and value the individual qualities you bring, enabling you to be impactful, to be entrepreneurial, to be empowered, and to create value beyond wealth. Let’s shape the future of wealth management
At Julius Baer, we celebrate and value the individual qualities you bring, enabling you to be impactful, to be entrepreneurial, to be empowered, and to create value beyond wealth. Let’s shape the future of wealth management
Job Description: For over 150 years, our dedication to being the Global Hausbank for our clients has been driven by our people – in around 60 countries and across more than 150 nationalities. Their deep understanding,
Your future starts here In the Midrange Protection team, you work at the intersection of security engineering, automation and large-scale operations. We provide and operate enterprise security services that are based on agents and backend systems and integrate
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON)
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON)
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON)
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON)